Literature DB >> 30530624

Divergent Cytotoxic and Metabolically Stimulative Functions of Sigma-2 Receptors: Structure-Activity Relationships of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79) Derivatives.

Hilary E Nicholson1, Walid F Alsharif1, Anthony B Comeau1, Christophe Mesangeau1, Sebastiano Intagliata1, Marco Mottinelli1, Christopher R McCurdy1, Wayne D Bowen2.   

Abstract

Sigma-2 receptors, recently identified as TMEM97, have been implicated in cancer and neurodegenerative disease. Structurally distinct sigma-2 receptor ligands induce cell death in tumor cells, linking sigma-2 receptors to apoptotic pathways. Recently, we reported that sigma-2 receptors can also stimulate glycolytic hallmarks, effects consistent with a prosurvival function and upregulation in cancer cells. Both apoptotic and metabolically stimulative effects were observed with compounds related to the canonical sigma-2 antagonist SN79. Here we investigate a series of 6-substituted SN79 analogs to assess the structural determinants governing these divergent effects. Substitutions on the benzoxazolone ring of the core SN79 structure resulted in high-affinity sigma-2 receptor ligands (K i = 0.56-17.9 nM), with replacement of the heterocyclic oxygen by N-methyl (producing N-methylbenzimidazolones) generally decreasing sigma-1 affinity and a sulfur substitution (producing benzothiazolones) imparting high affinity at both subtypes, lowering subtype selectivity. Substitution at the 6-position with COCH3, NO2, NH2, or F resulted in ligands that were not cytotoxic. Five of these ligands induced an increase in metabolic activity, as measured by increased reduction of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) in human SK-N-SH neuroblastoma cells, further supporting a role for sigma-2 receptors in metabolism. Substitution with 6-isothiocyanate resulted in ligands that were sigma-2 selective and that irreversibly bound to the sigma-2 receptor, but not to the sigma-1 receptor. These ligands induced cell death upon both acute and continuous treatment (EC50 = 7.6-32.8 μM), suggesting that irreversible receptor binding plays a role in cytotoxicity. These ligands will be useful for further study of these divergent roles of sigma-2 receptors.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30530624      PMCID: PMC6346378          DOI: 10.1124/jpet.118.253484

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  28 in total

1.  Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease.

Authors:  Bitna Yi; James J Sahn; Pooneh Memar Ardestani; Andrew K Evans; Luisa L Scott; Jessica Z Chan; Sangeetha Iyer; Ashley Crisp; Gabriella Zuniga; Jonathan T Pierce; Stephen F Martin; Mehrdad Shamloo
Journal:  J Neurochem       Date:  2017-02       Impact factor: 5.372

2.  Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells.

Authors:  B J Vilner; W D Bowen
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

3.  Progesterone inhibits apoptosis in part by PGRMC1-regulated gene expression.

Authors:  J J Peluso; X Liu; A Gawkowska; V Lodde; C A Wu
Journal:  Mol Cell Endocrinol       Date:  2010-02-06       Impact factor: 4.102

4.  Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.

Authors:  Keith W Crawford; Wayne D Bowen
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

5.  Sigma 2 receptors as potential biomarkers of proliferation in breast cancer.

Authors:  R H Mach; C R Smith; I al-Nabulsi; B R Whirrett; S R Childers; K T Wheeler
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

6.  Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells.

Authors:  Zhiping Wu; Wayne D Bowen
Journal:  J Biol Chem       Date:  2008-06-06       Impact factor: 5.157

7.  Progesterone receptor membrane component 1--many tasks for a versatile protein.

Authors:  Ralf M Lösel; Daniela Besong; John J Peluso; Martin Wehling
Journal:  Steroids       Date:  2007-12-27       Impact factor: 2.668

8.  Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site.

Authors:  Jinbin Xu; Chenbo Zeng; Wenhua Chu; Fenghui Pan; Justin M Rothfuss; Fanjie Zhang; Zhude Tu; Dong Zhou; Dexing Zeng; Suwanna Vangveravong; Fabian Johnston; Dirk Spitzer; Katherine C Chang; Richard S Hotchkiss; William G Hawkins; Kenneth T Wheeler; Robert H Mach
Journal:  Nat Commun       Date:  2011-07-05       Impact factor: 14.919

9.  Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.

Authors:  Nicholas J Izzo; Agnes Staniszewski; Lillian To; Mauro Fa; Andrew F Teich; Faisal Saeed; Harrison Wostein; Thomas Walko; Anisha Vaswani; Meghan Wardius; Zanobia Syed; Jessica Ravenscroft; Kelsie Mozzoni; Colleen Silky; Courtney Rehak; Raymond Yurko; Patricia Finn; Gary Look; Gilbert Rishton; Hank Safferstein; Miles Miller; Conrad Johanson; Edward Stopa; Manfred Windisch; Birgit Hutter-Paier; Mehrdad Shamloo; Ottavio Arancio; Harry LeVine; Susan M Catalano
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

10.  Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.

Authors:  Nicholas J Izzo; Jinbin Xu; Chenbo Zeng; Molly J Kirk; Kelsie Mozzoni; Colleen Silky; Courtney Rehak; Raymond Yurko; Gary Look; Gilbert Rishton; Hank Safferstein; Carlos Cruchaga; Alison Goate; Michael A Cahill; Ottavio Arancio; Robert H Mach; Rolf Craven; Elizabeth Head; Harry LeVine; Tara L Spires-Jones; Susan M Catalano
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

View more
  8 in total

1.  Exploring 1-adamantanamine as an alternative amine moiety for metabolically labile azepane ring in newly synthesized benzo[d]thiazol-2(3H)one σ receptor ligands.

Authors:  Sebastiano Intagliata; Hebaalla Agha; Theresa A Kopajtic; Jonathan L Katz; Shyam H Kamble; Abhisheak Sharma; Bonnie A Avery; Christopher R McCurdy
Journal:  Med Chem Res       Date:  2020-07-08       Impact factor: 1.965

2.  Benzimidazolone-based selective σ2 receptor ligands: Synthesis and pharmacological evaluation.

Authors:  Sebastiano Intagliata; Walid F Alsharif; Christophe Mesangeau; Nicola Fazio; Michael Seminerio; Yan-Tong Xu; Rae R Matsumoto; Christopher R McCurdy
Journal:  Eur J Med Chem       Date:  2019-01-09       Impact factor: 6.514

3.  Synthesis and Molecular Modelling Studies of New 1,3-Diaryl-5-Oxo-Proline Derivatives as Endothelin Receptor Ligands.

Authors:  Sebastiano Intagliata; Mohamed A Helal; Luisa Materia; Valeria Pittalà; Loredana Salerno; Agostino Marrazzo; Alfredo Cagnotto; Mario Salmona; Maria N Modica; Giuseppe Romeo
Journal:  Molecules       Date:  2020-04-17       Impact factor: 4.411

4.  Novel thymoquinone lipidic core nanocapsules with anisamide-polymethacrylate shell for colon cancer cells overexpressing sigma receptors.

Authors:  Lydia Ramzy; Abdelkader A Metwally; Maha Nasr; Gehanne A S Awad
Journal:  Sci Rep       Date:  2020-07-03       Impact factor: 4.379

5.  Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective.

Authors:  Antonino N Fallica; Valeria Pittalà; Maria N Modica; Loredana Salerno; Giuseppe Romeo; Agostino Marrazzo; Mohamed A Helal; Sebastiano Intagliata
Journal:  J Med Chem       Date:  2021-06-02       Impact factor: 7.446

6.  Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity.

Authors:  Giuseppe Romeo; Valeria Ciaffaglione; Emanuele Amata; Maria Dichiara; Loredana Calabrese; Luca Vanella; Valeria Sorrenti; Salvo Grosso; Agata Grazia D'Amico; Velia D'Agata; Sebastiano Intagliata; Loredana Salerno
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

7.  Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity.

Authors:  Cheri Z Liu; Marco Mottinelli; Hilary E Nicholson; Bridget M McVeigh; Neelum K Wong; Christopher R McCurdy; Wayne D Bowen
Journal:  Eur J Pharmacol       Date:  2021-06-16       Impact factor: 5.195

Review 8.  Proceedings from the Fourth International Symposium on σ-2 Receptors: Role in Health and Disease.

Authors:  Nicholas J Izzo; Martí Colom-Cadena; Aladdin A Riad; Jinbin Xu; Meharvan Singh; Carmen Abate; Michael A Cahill; Tara L Spires-Jones; Wayne D Bowen; Robert H Mach; Susan M Catalano
Journal:  eNeuro       Date:  2020-11-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.